148
Participants
Start Date
December 9, 2019
Primary Completion Date
July 21, 2022
Study Completion Date
September 20, 2022
MEDI3506
multiple doses
Placebo
multiple doses
Research Site, East Melbourne
Research Site, Carlton
Research Site, Box Hill
Research Site, Fremantle
Research Site, Berlin
Research Site, Mahlow
Research Site, Hamburg
Research Site, Alcobendas
Research Site, Charlotte
Research Site, Leganés
Research Site, Spartanburg
Research Site, Jacksonville
Research Site, Orlando
Research Site, Miami
Research Site, Birmingham
Research Site, Memphis
Research Site, Seville
Research Site, Baton Rouge
Research Site, Tulsa
Research Site, San Antonio
Research Site, San Antonio
Research Site, Santa Monica
Research Site, Providence
Research Site, Dresden
Research Site, Bialystok
Research Site, Kielce
Research Site, Lodz
Research Site, Poznan
Research Site, Skierniewice
Research Site, Wroclaw
Research Site, Corby
Research Site, High Wycombe
Research Site, Kenilworth
Research Site, Northwood
Research Site, Romford
Research Site, Shipley
Research Site, Sidcup
Research Site, Wokingham
Lead Sponsor
AstraZeneca
INDUSTRY